Amicus Therapeutics Inc.

12/03/2021 | Press release | Distributed by Public on 12/03/2021 06:06

European Medicines Agency Validates Amicus Therapeutics Marketing Authorization Applications for AT-GAA for the Treatment of Pompe Disease